Tick-Borne Encephalitis (TBE) research hub

Tick-Borne Encephalitis (TBE) Remdesivir Efficacy Assessment Trial (TREAT) – A phase 2 proof-of-concept, national, multicenter, randomized, double-blind, placebo-controlled clinical study designed to evaluate the efficacy of remdesivir in adult patients hospitalized for TBE

This study is looking at remdesivir, a medicine, to see if it can help adults in hospital with Tick-Borne Encephalitis (TBE). We're checking if it reduces brain damage and improves mental abilities compared to a dummy drug.